According to block deal data of the day, Sepia Investments bought 43,28,943 shares of Corona Remedies at Rs. 1,730, which is roughly Rs. 748.9 crores translating into a deal value of Rs. Another vendor, Anchor Partners, raised about Rs. Offloaded 1,61,861 shares at par worth Rs 28 crore. Together, the two sellers have invested in the pharmaceutical company for approximately Rs. 776.9 crore shares were sold.
On the buy side, twelve investors each invested Rs. 1,730 shares were bought. HDFC Mutual Fund was the top buyer, adding around Rs. 423.9 crore worth 24,50,000 shares were acquired, which itself accounted for more than half of the total deal value.
Aberdeen Asian Smaller Companies Investment Trust Plc raised around Rs. 78 crore bought 4,50,868 shares, while Aditya Birla Sun Life Mutual Fund bought around Rs. 84.8 crore worth 4,90,000 shares were bought. Abu Dhabi Investment Authority through its ADIA has invested around Rs. 6.8 crore bought 39,130 shares.
Other buyers include Aberdeen Standard SICAV I – Asian Smaller Companies Fund, which raised around Rs. 47.4 crore bought 2,74,132 shares and Invesco Mutual Fund, which bought around Rs. 50 crore worth 2,89,017 shares were bought. Kotak Mahindra Mutual Fund has invested around Rs. Acquired 1,61,861 shares worth Rs 28 crore, which matched the exact quantity sold by Anchor Partners.
India Acorn ICAV – Ashoka WhiteOak Emerging Markets Equity Fund has invested around Rs. 25.7 crore bought 1,48,686 shares, while WhiteOak Capital Mutual Fund bought around Rs. Bought 1,45,000 shares worth Rs 25.1 crore. Includes the Ashoka WhiteOak Emerging Markets Equity x China Fund, which has invested around Rs. 5.1 crore bought 29,520 shares, Factory Mutual Insurance Company, which raised Rs. 1.9 crore worth bought 10,670 shares and TCW White Oak Emerging Markets was the smallest equity buy with 19,000 blocks. Around Rs. 33 lakh worth of shares.
As a trusted and reliable news source
Add now!
(You can now subscribe to our ETMarkets WhatsApp channel)